Chicagoland hospital partners with Ambry Genetics to sequence 10k genomes

Evanston, Ill.-based NorthShore University HealthSystem's center for personalized medicine will partner with Aliso Viejo, Calif.-based Ambry Genetics to offer 10,000 patients genetic testing.

Ambry will participate in NorthShore's genomic health initiative, performing whole exome sequencing on 10,000 patients enrolled in the research project. Ambry will compile the sequenced data and the patient's EMR information, which may provide insights into the link between genetic variation and disease.

"Preventing and managing disease through scientific excellence and high-quality care is the cornerstone of this partnership," said Aaron Elliott, PhD, CEO of Ambry. "NorthShore and Ambry share the same patient-first philosophy and focus on scientific innovation to improve the future of healthcare."

More articles on data analytics & precision medicine:

23andMe to expand with $200M in latest funding round
UC Davis to use precision medicine in pancreatic cancer care
Global genomic data platform WuXi NextCODE raises $240M

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months